Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Comparison of DNA ploidy, histologic, and immunohistochemical findings with clinical outcome in inflammatory myofibroblastic tumors.

Hussong JW, Brown M, Perkins SL, Dehner LP, Coffin CM.

Mod Pathol. 1999 Mar;12(3):279-86.

PMID:
10102613
3.

Inflammatory fibrosarcoma: update, reappraisal, and perspective on its place in the spectrum of inflammatory myofibroblastic tumors.

Meis-Kindblom JM, Kjellström C, Kindblom LG.

Semin Diagn Pathol. 1998 May;15(2):133-43.

PMID:
9606804
4.

Inflammatory myofibroblastic tumor (inflammatory pseudotumor): DNA flow cytometric analysis of nine pediatric cases.

Biselli R, Ferlini C, Fattorossi A, Boldrini R, Bosman C.

Cancer. 1996 Feb 15;77(4):778-84.

5.
6.

Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.

Giatromanolaki A, Sivridis E, Stathopoulos GP, Fountzilas G, Kalofonos HP, Tsamandas A, Vrettou E, Scopa C, Polychronidis A, Simopoulos K, Koukourakis MI.

Anticancer Res. 2001 Jan-Feb;21(1A):253-9.

PMID:
11299743
7.

Primary malignant epithelial tumors of the liver in children: a study of DNA content and oncogene expression.

Zerbini MC, Sredni ST, Grier H, Cristofani LM, Latorre MR, Hollister KA, Alves VA, Weinberg DS, Perez-Atayde AR.

Pediatr Dev Pathol. 1998 Jul-Aug;1(4):270-80.

PMID:
10463288
8.

Prognostic significance of bcl-2, bax, and p53 expression in diffuse large B-cell lymphoma.

Sohn SK, Jung JT, Kim DH, Kim JG, Kwak EK, Park Ti, Shin DG, Sohn KR, Lee KB.

Am J Hematol. 2003 Jun;73(2):101-7.

9.

c-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanoma.

Chana JS, Wilson GD, Cree IA, Alexander RA, Myatt N, Neale M, Foss AJ, Hungerford JL.

Br J Ophthalmol. 1999 Jan;83(1):110-4.

10.

Inflammatory myofibroblastic tumor of the central nervous system: clinicopathologic analysis of 10 cases.

Jeon YK, Chang KH, Suh YL, Jung HW, Park SH.

J Neuropathol Exp Neurol. 2005 Mar;64(3):254-9.

PMID:
15804057
11.
12.

Bcl-2, bax and p53 expression in rectal adenocarcinoma. Correlation with classic pathologic prognostic factors and patients' outcome.

Tsamandas AC, Kardamakis D, Petsas T, Zolota V, Vassiliou V, Matatsoris T, Kalofonos H, Vagianos CE, Scopa CD.

In Vivo. 2007 Jan-Feb;21(1):113-8. Erratum in: In Vivo. 2007 May-Jun;21(3):553. Zolota, V [added]; Vassiliou, V [added]; Matatsoris, T [added]. In Vivo. 2007 Nov-Dec;21(6):1172.

13.

Fibroma and inflammatory myofibroblastic tumor of the heart.

de Montpréville VT, Serraf A, Aznag H, Nashashibi N, Planché C, Dulmet E.

Ann Diagn Pathol. 2001 Dec;5(6):335-42.

PMID:
11745071
14.

Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma.

Montgomery EA, Shuster DD, Burkart AL, Esteban JM, Sgrignoli A, Elwood L, Vaughn DJ, Griffin CA, Epstein JI.

Am J Surg Pathol. 2006 Dec;30(12):1502-12.

PMID:
17122505
15.

Expression of Bcl-2, Bax and p53 proteins in pituitary adenomas: an immunohistochemical study.

Ozer E, Canda MS, Ulukus C, Guray M, Erbayraktar S.

Tumori. 2003 Jan-Feb;89(1):54-9.

PMID:
12729363
16.

Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors.

Can B, Sökmensüer C.

Hepatogastroenterology. 2003 Dec;50 Suppl 2:ccxliii-ccxlviii.

PMID:
15244191
17.

Myofibroblastic tumours: neoplasias with divergent behaviour. Ultrastructural and flow cytometric analysis.

Biselli R, Boldrini R, Ferlini C, Boglino C, Inserra A, Bosman C.

Pathol Res Pract. 1999;195(9):619-32.

PMID:
10507082
18.

The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue.

Xie X, Clausen OP, De Angelis P, Boysen M.

Cancer. 1999 Sep 15;86(6):913-20.

PMID:
10491515
19.

Atypical bronchopulmonary carcinoids show a tendency toward increased apoptotic and proliferative activity.

Laitinen KL, Soini Y, Mattila J, Pääkkö P.

Cancer. 2000 Apr 1;88(7):1590-8.

PMID:
10738217
20.

Apoptosis and proliferative activity in mature and immature teratomas of the mediastinum.

Hiroshima K, Toyozaki T, Iyoda A, Yusa T, Fujisawa T, Ohwada H.

Cancer. 2001 Oct 1;92(7):1798-806.

PMID:
11745252

Supplemental Content

Support Center